360 related articles for article (PubMed ID: 19005291)
1. The relationships between PON1 activity as well as oxLDL levels and coronary artery lesions in CHD patients with diabetes mellitus or impaired fasting glucose.
Lu C; Gao Y; Zhou H; Tian H
Coron Artery Dis; 2008 Dec; 19(8):565-73. PubMed ID: 19005291
[TBL] [Abstract][Full Text] [Related]
2. Paraoxonase, oxidized low density lipoprotein, monocyte chemoattractant protein-1 and adhesion molecules are associated with macrovascular complications in patients with type 2 diabetes mellitus.
Sozer V; Himmetoglu S; Korkmaz GG; Kaya S; Aydin S; Yumuk V; Hatemi H; Uzun H
Minerva Med; 2014 Jun; 105(3):237-44. PubMed ID: 24988089
[TBL] [Abstract][Full Text] [Related]
3. Low paraoxonase 1 arylesterase activity and high von Willebrand factor levels are associated with severe coronary atherosclerosis in patients with non-diabetic stable coronary artery disease.
Ding J; Chen Q; Zhuang X; Feng Z; Xu L; Chen F
Med Sci Monit; 2014 Nov; 20():2421-9. PubMed ID: 25420483
[TBL] [Abstract][Full Text] [Related]
4. Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease.
Toprak O; Cirit M; Yesil M; Bayata S; Tanrisev M; Varol U; Ersoy R; Esi E
Nephrol Dial Transplant; 2007 Mar; 22(3):819-26. PubMed ID: 17090607
[TBL] [Abstract][Full Text] [Related]
5. Serum oxidized low density lipoprotein, paraoxonase 1 and lipid peroxidation levels during oral glucose tolerance test.
Serin O; Konukoglu D; Firtina S; Mavis O
Horm Metab Res; 2007 Mar; 39(3):207-11. PubMed ID: 17373636
[TBL] [Abstract][Full Text] [Related]
6. [Relationships between PON1 L55M polymorphism and coronary heart diseases complicated with fasting hyperglycemia in Han populations in Guangdong].
Zhou H; Lu CZ; Gao Y; Long Y; Tian HM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):68-72. PubMed ID: 19292048
[TBL] [Abstract][Full Text] [Related]
7. Angiographic coronary artery disease is associated with progressively higher levels of fasting plasma glucose.
Quadros AS; Sarmento-Leite R; Bertoluci M; Duro K; Schmidt A; De Lucca G; Schaan BD
Diabetes Res Clin Pract; 2007 Feb; 75(2):207-13. PubMed ID: 16887232
[TBL] [Abstract][Full Text] [Related]
8. High-density lipoprotein composition and paraoxonase activity in Type I diabetes.
Valabhji J; McColl AJ; Schachter M; Dhanjil S; Richmond W; Elkeles RS
Clin Sci (Lond); 2001 Dec; 101(6):659-70. PubMed ID: 11724654
[TBL] [Abstract][Full Text] [Related]
9. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
[TBL] [Abstract][Full Text] [Related]
10. Serum autoantibodies against human oxidized low-density lipoproteins are inversely associated with severity of coronary stenotic lesions calculated by Gensini score.
Che J; Li G; Wang W; Li Q; Liu H; Chen K; Liu T
Cardiol J; 2011; 18(4):364-70. PubMed ID: 21769816
[TBL] [Abstract][Full Text] [Related]
11. Association analysis between endothelial function related factors and coronary artery stenosis degree in coronary heart disease patients with type 2 diabetes mellitus.
Li Q; Zhang Z; Du R; Hu X; Yan Y; Gao Q; Fan Y
J Pediatr Endocrinol Metab; 2012; 25(7-8):711-6. PubMed ID: 23155698
[TBL] [Abstract][Full Text] [Related]
12. Low protective PON1 lactonase activity in an Arab population with high rates of coronary heart disease and diabetes.
Gugliucci A; Caccavello R; Nassar H; Abu Ahmad W; Sinnreich R; Kark JD
Clin Chim Acta; 2015 May; 445():41-7. PubMed ID: 25801214
[TBL] [Abstract][Full Text] [Related]
13. Relationship among plasma secretory phospholipase A2, oxidized low density lipoprotein & paraoxonase activities in hypertensive subjects treated with angiotensin converting enzyme inhibitors.
Konukoglu D; Firtina S; Serin O; Cavusoglu C
Indian J Med Res; 2009 Apr; 129(4):390-4. PubMed ID: 19535833
[TBL] [Abstract][Full Text] [Related]
14. Impaired fasting glucose is associated with increased severity of subclinical coronary artery disease compared to patients with diabetes and normal fasting glucose: evaluation by coronary computed tomographic angiography.
Gurudevan S; Garg P; Malik S; Khattar R; Saremi F; Hecht H; DeMaria A; Narula J
BMJ Open; 2016 Aug; 6(8):e005148. PubMed ID: 27531720
[TBL] [Abstract][Full Text] [Related]
15. Defective metabolism of oxidized phospholipid by HDL from people with type 2 diabetes.
Mastorikou M; Mackness M; Mackness B
Diabetes; 2006 Nov; 55(11):3099-103. PubMed ID: 17065348
[TBL] [Abstract][Full Text] [Related]
16. Quantitative assessment of the influence of paraoxonase 1 activity and coronary heart disease risk.
Wang M; Lang X; Cui S; Zou L; Cao J; Wang S; Wu X
DNA Cell Biol; 2012 Jun; 31(6):975-82. PubMed ID: 22320866
[TBL] [Abstract][Full Text] [Related]
17. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population.
Meisinger C; Baumert J; Khuseyinova N; Loewel H; Koenig W
Circulation; 2005 Aug; 112(5):651-7. PubMed ID: 16043640
[TBL] [Abstract][Full Text] [Related]
18. Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease.
Haraguchi Y; Toh R; Hasokawa M; Nakajima H; Honjo T; Otsui K; Mori K; Miyamoto-Sasaki M; Shinohara M; Nishimura K; Ishida T; Hirata K
Atherosclerosis; 2014 Jun; 234(2):288-94. PubMed ID: 24704632
[TBL] [Abstract][Full Text] [Related]
19. [The relationship between microalbuminuria and coronary artery lesions].
Wang Y; Li Y
Zhonghua Nei Ke Za Zhi; 2007 Dec; 46(12):981-3. PubMed ID: 18478911
[TBL] [Abstract][Full Text] [Related]
20. Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study.
Mackness B; Durrington P; McElduff P; Yarnell J; Azam N; Watt M; Mackness M
Circulation; 2003 Jun; 107(22):2775-9. PubMed ID: 12756158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
